Award
Delivery Order #SPE2DR26FMJX4
Delivery Order for Midazolam Hydrochloride Under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$25.50
Ceiling
$25.50
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FMJX4
NAICS
424210
This award is a delivery order contract allocated to DMS Pharmaceutical Group Inc., a specialized pharmaceutical services provider. It pertains to the procurement of Midazolam Hydrochloride, a critical pharmaceutical product used in healthcare applications. The contract supports ongoing agency efforts to maintain a reliable supply of essential medications, contributing significantly to public health readiness. The scope of work includes the delivery and supply of Midazolam Hydrochloride within a brief, specified timeframe in early 2026. This contract is a supplement to a larger indefinite delivery vehicle (IDV) agreement previously established with DMS Pharmaceutical Group, which was competitively awarded to ensure optimal pharmaceutical resource acquisition. The parent IDV contract facilitates long-term service continuity through 2036, underpinning the agency's pharmaceutical supply chain management strategy. This current delivery order reflects a focused fulfillment of specific pharmaceutical needs under the broader established contract framework.
Description
4571140587! MIDAZOLAM HYDROCHLORI